Kinfo
Enovis Corporation logo

Enovis Corporation

ENOVNYSEHealthcare·US · USD
$17.77
-0.28 (-1.55%)
Prices as of October 2, 2026 · market closed

Price

Key statistics

Valuation
Market cap1.02B USD
Enterprise value2.38B USD
Trailing P/E-0.86
Forward P/E4.88
PEG ratio0.01
Price / sales0.45
Price / book0.69
Profitability
Gross margin61.64%
Operating margin4.18%
Profit margin-47.97%
Return on assets1.20%
Return on equity-54.14%
Income (TTM)
Revenue2.30B USD
Gross profit1.41B USD
EBITDA369.35M USD
Net income-1.10B USD
Diluted EPS-$19.27
Rev. growth (YoY)3.20%
Balance sheet
Total cash12.56M USD
Total debt1.37B USD
Debt / equity92.56
Current ratio1.99
Book value / share$25.62
Cash flow (TTM)
Operating cash flow270.10M USD
Levered free cash flow185.94M USD
Shares & price
Shares outstanding57.67M
Float52.76M
Held by institutions124.43%
Beta1.43
50-day MA$23.04
200-day MA$23.80
52-week high$34.28
52-week low$17.30
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Recent payments
  • 2022-04-05$25.75
Earnings (EPS)
DateEst.ActualSurprise2026-08-060.850.90+5.88%2026-07-17-0.09-0.14−55.56%2026-05-070.810.89+9.88%2026-03-25-0.530.94+277.36%2026-02-260.840.95+13.10%
About Enovis Corporation

Enovis Corporation is a medical technology company focused on developing clinically differentiated solutions for musculoskeletal health. Enovis Corporation designs, manufactures, and distributes medical devices and services used across the patient care continuum, including injury prevention, rehabilitation, pain management, physical therapy, and reconstructive surgery. Its product portfolio includes orthopedic braces and supports, recovery and rehabilitation technologies, joint replacement implants, and surgical enabling tools that support hip, knee, shoulder, elbow, foot, ankle, and other extremity procedures. The company serves healthcare professionals and patients through two main business segments, Prevention & Recovery and Reconstructive, reflecting its role in both non-surgical treatment and surgical care. Enovis Corporation operates in the orthopedic and broader medical device markets, where it provides solutions intended to improve mobility, restore function, and support clinical workflows across hospitals, outpatient settings, and other care environments.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Damien McDonald
Employees
7,367
Headquarters
Wilmington, DE, United States

Frequently asked questions about Enovis Corporation